Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
INGN - Inogen, Inc
Market Cap 175.26M P/E - EPS this Y 56.60% Ern Qtrly Grth -
Income -92.44M Forward P/E -4.65 EPS next Y 12.50% 50D Avg Chg -25.00%
Sales 326.65M PEG 0.02 EPS past 5Y -11.83% 200D Avg Chg -54.00%
Dividend N/A Price/Book 0.62 EPS next 5Y -207.80% 52W High Chg -76.00%
Recommedations 2.70 Quick Ratio 2.14 Shares Outstanding 23.72M 52W Low Chg 1.00%
Insider Own 1.79% ROA -10.00% Shares Float 19.14M Beta 1.05
Inst Own 95.98% ROE -39.99% Shares Shorted/Prior 0.98M/1.35M Price 7.58
Gross Margin 42.56% Profit Margin -28.30% Avg. Volume 417,551 Target Price 10.00
Oper. Margin -7.49% Earnings Date Nov 5 Volume 211,604 Change -3.93%
Healthcare | Medical Devices | United States
About Inogen, Inc

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Inogen, Inc News
12/21/24 Inogen, Inc. (NASDAQ:INGN) is a favorite amongst institutional investors who own 78%
12/12/24 The Zacks Analyst Blog Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen
12/11/24 5 Medical Device Stocks That Survived the 2024 Market Volatility
11/25/24 Inogen (INGN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
11/11/24 INGN Stock Gains Following Q3 Earnings Beat, Adjusted Gross Margin Up
11/10/24 US$10.00 - That's What Analysts Think Inogen, Inc. (NASDAQ:INGN) Is Worth After These Results
11/09/24 Inogen Third Quarter 2024 Earnings: Beats Expectations
11/08/24 Inogen (INGN) Reports Q3 Earnings: What Key Metrics Have to Say
11/08/24 Inogen Inc (INGN) Q3 2024 Earnings Call Highlights: Strong B2B Growth Amidst DTC Challenges
11/07/24 Inogen (INGN) Reports Q3 Loss, Tops Revenue Estimates
11/07/24 Inogen: Q3 Earnings Snapshot
11/07/24 Inogen Announces Third Quarter 2024 Financial Results
11/07/24 Sight Sciences Appoints MK Raheja as Executive Vice President, Research and Development and Brenton Taylor as Executive Vice President, Operations
11/07/24 Inogen, Inc. (INGN): A Bear Case Theory
11/04/24 Inogen to Present at Upcoming Investor Conferences
10/18/24 Here's Why You Should Retain Inogen Stock in Your Portfolio Now
10/17/24 Inogen to Report Third Quarter 2024 Financial Results on November 7, 2024
10/09/24 Inogen Inc (INGN) Q2 2024 Earnings Call Highlights: Strong B2B Growth Amid DTC Challenges
10/08/24 Inogen Launches Rove 4 Portable Oxygen Concentrator, Delivering the Highest Oxygen Output in the Lightest Weight 4-Setting POC
10/04/24 Inogen Stock Rises 47% in 6 Months: What's Driving the Rally?
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Glezer Stanislav EVP, Chief Technolog.. EVP, Chief Technology Officer Sep 01 Option 0 3,075 3,075 09/06/22
Glezer Stanislav EVP, Chief Technolog.. EVP, Chief Technology Officer Sep 01 Sell 28.16 1,576 44,380 1,499 09/06/22
Somer Jason EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary Sep 01 Option 0 2,306 2,306 09/06/22
Somer Jason EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary Sep 01 Sell 28.16 1,145 32,243 1,161 09/06/22
Anderson Ray Benjamin M Director Director Mar 03 Sell 34.6809 4,516 156,619 03/07/22
McFarland Loren L Director Director Jan 11 Option 8.37 2,083 17,435 22,191 01/13/22
Huggenberger Raymond Director Director Aug 18 Sell 62.42 6,594 411,597 17,583 08/18/21
Huggenberger Raymond Director Director Aug 18 Option 38.54 6,594 254,133 24,177 08/18/21
Taylor Brenton EVP, Engineering EVP, Engineering Apr 19 Option 38.54 2,841 109,492 59,774 04/19/21
Taylor Brenton EVP, Engineering EVP, Engineering Apr 19 Sell 65.21 2,841 185,262 56,933 04/19/21
Taylor Brenton EVP, Engineering EVP, Engineering Apr 15 Sell 60.11 7,942 477,394 56,933 04/15/21
Taylor Brenton EVP, Engineering EVP, Engineering Apr 15 Option 38.54 7,942 306,085 63,037 04/15/21
Bauerlein Alison EVP, Finance, & CFO EVP, Finance, & CFO Apr 15 Option 38.54 2,841 109,492 4,965 04/15/21
Bauerlein Alison EVP, Finance, & CFO EVP, Finance, & CFO Apr 15 Sell 60.07 2,841 170,659 3,324 04/15/21
Bauerlein Alison EVP, Finance, & CFO EVP, Finance, & CFO Feb 18 Option 16.62 18,098 300,789 20,413 02/18/21
Bauerlein Alison EVP, Finance, & CFO EVP, Finance, & CFO Feb 18 Sell 54.51 18,098 986,522 2,315 02/18/21
GREER R SCOTT Director Director Feb 04 Option 44.69 20,000 893,800 28,021 02/04/21
Bauerlein Alison EVP, Finance, & CFO EVP, Finance, & CFO Jan 20 Option 16.62 18,098 300,789 20,413 01/20/21
Bauerlein Alison EVP, Finance, & CFO EVP, Finance, & CFO Jan 20 Sell 44.55 18,098 806,266 2,315 01/20/21
Taylor Brenton EVP, Engineering EVP, Engineering Jan 11 Option 16.62 11,017 183,103 67,609 01/11/21
Taylor Brenton EVP, Engineering EVP, Engineering Jan 11 Sell 47.19 11,017 519,892 56,592 01/11/21
Bauerlein Alison EVP, Finance, & CFO EVP, Finance, & CFO Dec 16 Option 16.62 8,702 144,627 11,017 12/16/20
Bauerlein Alison EVP, Finance, & CFO EVP, Finance, & CFO Dec 16 Sell 40.4 8,702 351,561 2,315 12/16/20